# Amgen: what changed between 2025-11-08 and 2026-11-08 entity: /record/amgen.md from: 2025-11-08 to: 2026-11-08 page: /record/amgen/diff?from=2025-11-08&to=2026-11-08 json: /v1/entities/amgen/diff?from=2025-11-08&to=2026-11-08 Between 2025-11-08 and 2026-11-08, Amgen's record changed in 17 facts: 3 replaced (net income $4.09 billion → $7.71 billion; operating income $7.26 billion → $9.08 billion; revenue $33.42 billion → $36.75 billion), 7 added, 7 ended; 11 unchanged. State as of 2025-11-08: /record/amgen.md?as_of=2025-11-08 · as of 2026-11-08: /record/amgen.md?as_of=2026-11-08. Format: subject | predicate | value | valid range | confidence | status | claim. Posts and Hugging Face repos are left out (0 held on 2025-11-08, 0 on 2026-11-08). ## Replaced (3) The same fact with a different value: the claim that held on the earlier day, then the one that holds on the later day. - net income: $4.09 billion → $7.71 billion - [Amgen](/record/amgen.md) | net_income | 4,090,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_70EECF48CD48](/claim/clm_70EECF48CD48.md) | [clm_ED179BBDEBC9](/claim/clm_ED179BBDEBC9.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm - [Amgen](/record/amgen.md) | net_income | 7,711,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_70EECF48CD48](/claim/clm_70EECF48CD48.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm - operating income: $7.26 billion → $9.08 billion - [Amgen](/record/amgen.md) | operating_income | 7,258,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_92AC0DE5846F](/claim/clm_92AC0DE5846F.md) | [clm_14D79C128253](/claim/clm_14D79C128253.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm - [Amgen](/record/amgen.md) | operating_income | 9,080,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_92AC0DE5846F](/claim/clm_92AC0DE5846F.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm - revenue: $33.42 billion → $36.75 billion - [Amgen](/record/amgen.md) | revenue | 33,424,000,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_3DD4895A6205](/claim/clm_3DD4895A6205.md) | [clm_F31DA2CA4F3F](/claim/clm_F31DA2CA4F3F.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000010/0000318154-25-000010-index.htm - [Amgen](/record/amgen.md) | revenue | 36,751,000,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_3DD4895A6205](/claim/clm_3DD4895A6205.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000010/0000318154-26-000010-index.htm ## Added (7) Held on 2026-11-08, not on 2025-11-08. - [Amgen](/record/amgen.md) | cash_and_equivalents | 13,190,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_682A30955369](/claim/clm_682A30955369.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm - [Amgen](/record/amgen.md) | quarterly_net_income | 3,864,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_92C83000279C](/claim/clm_92C83000279C.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm - [Amgen](/record/amgen.md) | quarterly_operating_income | 3,710,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_B7EB0BB6DBEB](/claim/clm_B7EB0BB6DBEB.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm - [Amgen](/record/amgen.md) | quarterly_revenue | 10,365,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_985DF46177C9](/claim/clm_985DF46177C9.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm - [Amgen](/record/amgen.md) | shares_outstanding | 540,911,490 shares | valid 2026-10-29 to present | conf 0.95 | valid | [clm_E74CF4B58FED](/claim/clm_E74CF4B58FED.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm - [Amgen](/record/amgen.md) | total_assets | 96,048,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_8D59A495A2F7](/claim/clm_8D59A495A2F7.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm - [Amgen](/record/amgen.md) | total_equity | 14,352,000,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_1845D943407A](/claim/clm_1845D943407A.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm ## Ended (7) Held on 2025-11-08, not on 2026-11-08, and not replaced by another value. - [Amgen](/record/amgen.md) | cash_and_equivalents | 9,445,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_F9355A194FAC](/claim/clm_F9355A194FAC.md) | [clm_8E5607E4B59B](/claim/clm_8E5607E4B59B.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm - [Amgen](/record/amgen.md) | quarterly_net_income | 3,216,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_B9855476A1FF](/claim/clm_B9855476A1FF.md) | [clm_E7FF81925833](/claim/clm_E7FF81925833.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm - [Amgen](/record/amgen.md) | quarterly_operating_income | 2,526,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_8FA61AE28EA3](/claim/clm_8FA61AE28EA3.md) | [clm_A957F605C563](/claim/clm_A957F605C563.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm - [Amgen](/record/amgen.md) | quarterly_revenue | 9,557,000,000 United States dollar | valid 2025-09-30 to 2026-03-31 | conf 0.95 | superseded | superseded_by [clm_BA3B03AF2A85](/claim/clm_BA3B03AF2A85.md) | [clm_56EFD8BFD444](/claim/clm_56EFD8BFD444.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm - [Amgen](/record/amgen.md) | shares_outstanding | 538,480,671 shares | valid 2025-10-30 to 2026-02-10 | conf 0.95 | superseded | superseded_by [clm_231B73F793B2](/claim/clm_231B73F793B2.md) | [clm_2EA05ED8BE57](/claim/clm_2EA05ED8BE57.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm - [Amgen](/record/amgen.md) | total_assets | 90,141,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_D061D89A7312](/claim/clm_D061D89A7312.md) | [clm_A3A1C9D984F8](/claim/clm_A3A1C9D984F8.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm - [Amgen](/record/amgen.md) | total_equity | 9,619,000,000 United States dollar | valid 2025-09-30 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_DEE8552AC913](/claim/clm_DEE8552AC913.md) | [clm_25EEFB9574DF](/claim/clm_25EEFB9574DF.md) sources: https://www.sec.gov/Archives/edgar/data/318154/000031815425000072/0000318154-25-000072-index.htm ## Unchanged 11 claims held on both days: chair 1, cik 1, fiscal_year_end 1, headquarters 1, listed_on 1, registrant_name 1, sic_industry 1, state_of_incorporation 1, ticker 1, website 1, x_username 1. ## Get this data - JSON: /v1/entities/amgen/diff?from=2025-11-08&to=2026-11-08 - MCP: entity_diff(entity: "amgen", from: "2025-11-08", to: "2026-11-08") - Entity twin: /record/amgen.md · timeline: /timelines/amgen.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.